An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top Of A Statin And Suppresses Hepatocyte SREBP-Regulated Genes

<p>Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a promising therapeutic target for treating coronary heart disease. We report a novel antibody 1B20 that binds to PCSK9 with sub-nanomolar affinity and antagonizes PCSK9 function <i>in-vitro</i>. In CETP/LDLR-hemi mice two...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsman: Liwen Zhang, Timothy McCabe, Jon H. Condra, Yan G. Ni, Laurence B. Peterson, Weirong Wang, Alison M. Strack, Fubao Wang, Shilpa Pandit, Holly Hammond, Dana Wood, Dale Lewis, Ray Rosa, Vivienne Mendoza, Anne Marie Cumiskey, Douglas G. Johns, Barbara C. Han
Materialtyp: Artigo
Språk:Inglês
Publicerad: Ivyspring International Publisher 2012-01-01
Serie:International Journal of Biological Sciences
Länkar:http://www.biolsci.org/v08p0310.htm
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk